| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |